| Identification | Back Directory | [Name]
Batefenterol | [CAS]
743461-65-6 | [Synonyms]
Batefenterol
GSK-961081,Batefenterol
Batefenterol(GSK961081)
GSK-961081(Batefenterol/TD-5959)
GSK961081;GSK-961081;GSK 961081;TD-5959;TD 5959;TD5959;BATEFENTEROL
Batefenterol, 98%, a novel muscarinic receptor antagonist and β2-adrenoceptor agonist
(R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate
Carbamic acid, N-[1,1'-biphenyl]-2-yl-, 1-[3-[[2-chloro-4-[[[(2R)-2-(1,2-dihydro-8-hydroxy-2-oxo-5-quinolinyl)-2-hydroxyethyl]amino]methyl]-5-methoxyphenyl]amino]-3-oxopropyl]-4-piperidinyl ester | [Molecular Formula]
C40H42ClN5O7 | [MDL Number]
MFCD27987925 | [MOL File]
743461-65-6.mol | [Molecular Weight]
740.24 |
| Chemical Properties | Back Directory | [Boiling point ]
948.3±65.0 °C(Predicted) | [density ]
1.41±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO:67.0(Max Conc. mg/mL);90.51(Max Conc. mM) | [form ]
A crystalline solid | [pka]
8.89±0.20(Predicted) |
|
|